PRESS RELEASES

Date	Title and Summary	Additional Formats
Toggle SummaryOct 5, 2010	Almost 400 Surgeons Register for Integra LifeSciences Workshops at the American Society for Surgery of the Hand (ASSH) Annual Meeting PLAINSBORO, N.J., Oct. 5, 2010 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) will offer four workshops at the 65 th Annual Meeting of the American Society for Surgery of the Hand (ASSH) on October 7-9 in Boston, Massachusetts.	View HTML Almost 400 Surgeons Register for Integra LifeSciences Workshops at the American Society for Surgery of the Hand (ASSH) Annual Meeting 19 KB
Toggle SummaryJun 9, 2003	Court Upholds Integra LifeSciences Patents Court Upholds Integra LifeSciences Patents Finding of Infringement by Merck KGaA upheld; Case Remanded For New Damages Calculation Plainsboro, NJ /June 9, 2003 / -- Integra LifeSciences Holdings Corporation (Nasdaq: IART) today announced that the United States Court of Appeals for the Federal	View HTML Court Upholds Integra LifeSciences Patents 12.1 KB
Toggle SummarySep 28, 2004	District Court Awards Integra LifeSciences $6.37 Million in Damages District Court Awards Integra LifeSciences $6.37 Million in Damages PLAINSBORO, N.J., Sept. 28, 2004 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that the United States District Court for the Southern District of California, ruling in the case Integra	View HTML District Court Awards Integra LifeSciences $6.37 Million in Damages 10.7 KB
Toggle SummaryJan 11, 2002	FDA Panel Recommends rhBMP-2 Product Including Integra LifeSciences Absorbable Collagen Sponge FDA Panel Recommends rhBMP-2 Product Including Integra LifeSciences Absorbable Collagen Sponge PLAINSBORO, N.J.--(BUSINESS WIRE)--Jan. 11, 2002--Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that the Orthopedic and Rehabilitation Devices Panel of the United States Food and	View HTML FDA Panel Recommends rhBMP-2 Product Including Integra LifeSciences Absorbable Collagen Sponge 12.3 KB
Toggle SummaryOct 17, 2001	Federal Judge Enters Final Post-Judgment Orders In Favor Of Integra Lifesciences -- Merck KGaA Held To Infringe Patents Federal Judge Enters Final Post-Judgment Orders In Favor Of Integra Lifesciences -- Merck KGaA Held To Infringe Patents PLAINSBORO, N.J.--(BUSINESS WIRE)--Oct. 17, 2001--Integra LifeSciences Holdings Corporation (NASDAQ:IART) announced today that the United States District Court for the Southern	View HTML Federal Judge Enters Final Post-Judgment Orders In Favor Of Integra Lifesciences -- Merck KGaA Held To Infringe Patents 14 KB
Toggle SummaryFeb 3, 2020	Integra Announces Amendment and Extension of Credit Facility and Private Placement of Convertible Senior Notes PRINCETON, N.J., Feb. 03, 2020 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART) today announced that it has amended and extended its credit facility and commenced a private offering of convertible senior notes. Amendment and Extension of Credit Facility Integra today	View HTML PDF Version
Toggle SummaryApr 26, 2006	Integra Announces Increased Use of NeuraGen Nerve Guide in Complex Peripheral Nerve Injuries Integra Announces Increased Use of NeuraGen Nerve Guide in Complex Peripheral Nerve Injuries PLAINSBORO, N.J., April 26, 2006 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that the NeuraGen® Nerve Guide is increasingly used in a wide variety of	View HTML Integra Announces Increased Use of NeuraGen Nerve Guide in Complex Peripheral Nerve Injuries 12.9 KB
Toggle SummaryJun 10, 2011	Integra Announces Pricing of Convertible Senior Notes PLAINSBORO, N.J., June 10, 2011 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced the pricing of $200,000,000 aggregate principal amount of 1.625% convertible senior notes due 2016 (the "notes"). The notes were offered and sold in a private placement solely	View HTML Integra Announces Pricing of Convertible Senior Notes 12.3 KB
Toggle SummaryFeb 4, 2020	Integra Announces Pricing of Convertible Senior Notes PRINCETON, N.J., Feb. 04, 2020 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART) today announced the pricing of $500,000,000 aggregate principal amount of 0.5% convertible senior notes due 2025 (the “Notes”). The Notes were offered and sold in a private placement solely to	View HTML PDF Version
Toggle SummaryJun 9, 2011	Integra Announces Private Placement of Convertible Senior Notes PLAINSBORO, N.J., June 9, 2011 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that it has commenced a private offering, subject to market conditions, of $200,000,000 aggregate principal amount of convertible senior notes due 2016.	View HTML Integra Announces Private Placement of Convertible Senior Notes 12 KB